Strategy Driven

MARCH 18, 2011

PL and CM: Coherent companies – those that possess a capabilities system that aligns their strategy with their product/service portfolio – generate superior performance over time, which is what we call the coherence premium. SD : What is the ‘coherence premium?’. SD : What does it mean to have a ‘right to win?’.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

DECEMBER 12, 2012

Based on data covering the period from 2005 to 2011, it charts how globalization has evolved since the onset of the financial crisis at the global, regional, and national levels. We compare the depth and breadth of 20 industries' global connectedness before delving into three case studies: pharmaceuticals, passenger cars and mobile phones.

Report 15

Report Merchandising GDP Globalization 15

Harvard Business Review

NOVEMBER 8, 2017

Still early in their health-care-modernization programs, many nations in the Middle East and Asia are already struggling with double-digit annual increases in health care expenditures, well above the rate of expansion of their gross domestic products. Over the same period, pharmaceutical exports have doubled. Insight Center.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

AUGUST 17, 2012

You could argue that Cipla's formula is simply to piggyback on other companies' products, so it doesn't have to pay for R&D. You could also argue that since Cipla produces many of its products in India, they pay less for labor and don't have to worry about quality. irketi in 2011 provided expansion in Turkey.

Company 11

Company Pharmaceuticals Business Model Fixed Costs 11

Harvard Business Review

JANUARY 12, 2011

A few years ago, pharmaceutical giant sanofi-aventis sponsored an anonymous, Web-based survey of 4,200 workers at four health care, transportation, and manufacturing companies. The second part was the 25-question Work Limitations Questionnaire , which aims to measure the affect of health-related problems on job performance and productivity.

Cost 15

Cost Absenteeism Pharmaceuticals Survey 15

Harvard Business Review

FEBRUARY 15, 2012

Several multinational corporations, such as America's Coach, are planning to move their production out of the province (and China) over the next five years, to other nations such as Vietnam and India. While Guangdong's exports accounted for as much as 37% of China's exports by 2000, its share dropped to 28% in 2011. Look at the data.

GDP 12

GDP Pharmaceuticals Long-term Globalization 12

Harvard Business Review

MAY 17, 2012

Enter jugaad innovation — a cost-effective approach for creating affordable products and services using limited resources. Realizing that their customers were doctors and parents in villages, they set out to identify the product features that would bring the most value to these rural users. million premature babies die each year.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

DECEMBER 27, 2016

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. As leaders, do physicians create a more sympathetic and productive work environment for other clinicians, because they are “one of them”?

Management 15

Management 360-Degree Feedback Mayo Training 15

In the CEO Afterlife

JUNE 19, 2011

by John • June 19, 2011 • Life , Marketing , Strategy • 1 Comment. As a young Brand Manager, I pounced on consumer insecurities, pumping products that solved bad breath, armpit odor, yellow teeth and bad skin. They know we can well afford their products. So do pharmaceutical giants Eli Lilly and Pfizer.

Advice 147

Advice Marketing Marketing Strategy Brand 147

Harvard Business Review

JUNE 16, 2016

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The private sector spends three times that , mostly on translational research intended to transform basic discoveries into new products. There is a wide chasm that separates an initial discovery and a viable product idea.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

OCTOBER 3, 2013

Take Citrus Lane CEO Mauria Finley, whose company was experiencing some growing pains, appropriately enough; the startup sends monthly packages of great baby products to moms. Back in 2011, in Citrus Lane’s first six months, its small founding team worked in a house and ate lunch together every day around a big table. After raising $5.1

Pharmaceuticals 8

Pharmaceuticals Seminar Learning-by-Doing Open-book 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 29, 2015

This is consistent with a 2011 article in the Journal of Finance, which also found that “patents of private equity-backed firms applied for in the years after the investment are more frequently cited.” All of this adds to the contentious debate over whether PE investors sacrifice long-term growth for short-term profit.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

FEBRUARY 24, 2015

These preparatory steps are of particular importance for carve-outs that are not full-fledged business units with profit & loss responsibility, such as R&D centers or production units whose only customer is their parent.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Eric Jacobson

JUNE 8, 2010

In its heyday, Marion had 3,400 employees with sales of nearly $1 billion and in 1989 merged with Merrell Dow Pharmaceuticals. The Kansas City Star newspaper recently featured a story about Marion Laboratories and its 60th anniversary. "Great Places To Work" Employee Perks New Book Shows You How To Set A Goal And Then Reac.

Mentor 56

Mentor Mission Statement Tips Open-book 56

Strategy Driven

JANUARY 24, 2011

You see, the responsibility for food safety is split between two agencies: The Agriculture Department is responsible for chickens, the grading of eggs for quality, and regulating liquid eggs that are used in industrial food production. Here are a few of this year’s headline makers and the lessons that can be learned from each of them.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 2, 2018

Workers’ increasing out-of-pocket costs are creating widespread discontent with the underlying costs of care — a problem largely driven by the high prices charged to private payers for health services and pharmaceuticals. Between 2011 and 2017, employees’ premiums and deductibles grew faster than their median income.

Health Care 8

Health Care Cost Insurance Price 8

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 10, 2013

The next few product launches were not nearly as successful and Ed Zander , a CEO who came in during the successful period, was unable to come up with any more hits. Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

NOVEMBER 21, 2013

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. In 1998, a group of horse ranchers suddenly set up a production facility and filed an Abbreviated New Drug Application (ANDA) for a generic version of Premarin. This, of course, represented a serious threat to a hugely profitable product.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 11, 2014

That’s because there are two primary types of uncertainty — demand uncertainty (will customers buy your product?) Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

MAY 25, 2017

In 2011 81 digital health startups received venture funding; with consistent year-over-year increases, 296 startups were venture backed in 2016. Stanley Healthcare, a division of Stanley Black & Decker Corporation, which sells products to over 17,000 hospitals and senior living facilities, offers a good example.

Health Care 9

Health Care Trends Venture Funding Technology 9